0001209191-22-021673.txt : 20220330
0001209191-22-021673.hdr.sgml : 20220330
20220330215403
ACCESSION NUMBER: 0001209191-22-021673
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220329
FILED AS OF DATE: 20220330
DATE AS OF CHANGE: 20220330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHREWSBURY STEPHEN B
CENTRAL INDEX KEY: 0001413821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40353
FILM NUMBER: 22788887
MAIL ADDRESS:
STREET 1: 2400 BAYSHORE PARKWAY
STREET 2: SUITE 200
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-29
0
0001445499
IMPEL NEUROPHARMA INC
IMPL
0001413821
SHREWSBURY STEPHEN B
C/O IMPEL NEUROPHARMA, INC.
201 ELLIOTT AVE. W, ST. 260
SEATTLE
WA
98119
0
1
0
0
Chief Medical Officer
Common Stock
2022-03-29
4
M
0
24606
1.97
A
97990
D
Stock Option (right to buy)
1.97
2022-03-29
4
M
0
24606
0.00
D
2027-02-13
Common Stock
24606
0
D
The option is 100% vested and exercisable.
/s/ John Leaman, M.D. as attorney-in-fact
2022-03-30